Kommentar
Flipping the fetal switch across β-hemoglobinopathies
Cell Stem Cell · 2026
DOI: 10.1016/j.stem.2026.09.003 ↗Kurz gefasst
Kommentar in der Zeitschrift Cell Stem Cell, 2026. Verfasst von Nishi Harwani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA. Hauptthemen laut MEDLINE: beta-Thalassemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
beta-ThalassemiaHumansAnemia, Sickle CellFetal HemoglobinPromoter Regions, Geneticbeta-Globins
Substanzen
Fetal Hemoglobinbeta-Globins
Autor:innen und Institutionen
- Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.
- Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: akshay.sharma@stjude.org.
Zitieren
APA
Harwani, N., & Sharma, A. (2026). Flipping the fetal switch across β-hemoglobinopathies. Cell Stem Cell. https://doi.org/10.1016/j.stem.2026.09.003
Vancouver
Harwani N, Sharma A. Flipping the fetal switch across β-hemoglobinopathies. Cell Stem Cell. 2026. doi:10.1016/j.stem.2026.09.003
BibTeX
@article{Harwani2026,
author = {Harwani, Nishi and Sharma, Akshay},
title = {Flipping the fetal switch across β-hemoglobinopathies},
journal = {Cell Stem Cell},
year = {2026},
doi = {10.1016/j.stem.2026.09.003}
}
EUVIMED